News - Alemtuzumab
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell.
DALLAS, December 8, 2011 /PRNewswire/ -- The report "Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)" analyzes and studies the major market
Biopharma intelligence provider will also moderate live panel on funding biopharma innovation at Prix Galien USA on September 27 in NYC. Norwood, MA (PRWEB)
In the first head-to-head comparison of the three most common drugs used at the time of a kidney transplant to prevent organ rejection, researchers found that the least expensive drug – at one-half to one-fifth the price – is as safe and effective as the other two.
EXTON, Pa., Nov. 2, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. has released a syndicated report focused on the management and treatment of multiple sclerosis (MS) in the US.
